ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "opportunistic infections and rheumatoid arthritis (RA)"

  • Abstract Number: 1227 • 2018 ACR/ARHP Annual Meeting

    Indicator Opportunistic Infections after Biological Treatment in Rheumatoid Arthritis, 10 Years Follow up in Clinical Practice

    Leticia Leon1,2, Marina Peñuelas3, Francisco Javier Candel3, Dalifer Freites Núñez4, Luis Rodriguez-Rodriguez5, Zulema Rosales Rosado6 and Lydia A Alcazar7, 1Rheumatology Department, Hospital Clínical San Carlos, and IdISSC, Madrid, Spain, 2Health Sciences, Universidad Camilo Jose Cela, Madrid, Spain, 3Microbiology, Microbiology Department. Hospital Clínico San Carlos, Madrid, Spain., Madrid, Spain, 4Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 5Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 6Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 7Rheumatology Department and Heath Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain

    Background/Purpose: Biologic disease-modifying anti-rheumatic drugs (bDMARDs) may be associated with opportunistic infections. Our purposes were to describe their incidence in Rheumatoid Arthritis (RA) taking bDMARDs,…
  • Abstract Number: 2410 • 2017 ACR/ARHP Annual Meeting

    Serious Infection Risk in Patients with Rheumatoid Arthritis Compared to Patients with Non-Inflammatory Rheumatic Diseases: A US National Cohort Study

    Bella Y. Mehta1, Sofia Pedro2, Gulsen Ozen3 and Kaleb Michaud4, 1Rheumatology, Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3Rheumatology, Marmara University, School of Medicine, Rheumatology, Istanbul, Turkey, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Serious infections (SI) in patients with rheumatoid arthritis (RA) are a perpetual concern. We compared the risk by first and recurrent SIs in patients…
  • Abstract Number: 482 • 2014 ACR/ARHP Annual Meeting

    Incidence of Opportunistic Infections in Rheumatoid Arthritis Treated with Biological Agents

    Alejandro Gomez-Gomez1,2, Zulema Rosales1,2, Leticia Leon2, Juan A Jover2, Luis Rodriguez-Rodriguez2 and Lydia Abasolo2, 1Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 2Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain

    Background/Purpose With the expanding use of Biological Agents (BA), in particular TNF inhibitors, opportunistic infections (OI) are a major concern in Rheumatology. Our purposes were…
  • Abstract Number: 2093 • 2012 ACR/ARHP Annual Meeting

    Rates of Opportunistic Infections Among Rheumatoid Arthritis Patients Switching Biologic Therapy

    John Baddley1, Shuo Yang2, Klye Brizendine3, Scott DuVall4, Kevin L. Winthrop5, Mary J. Burton6, Nivedita M. Patkar7, Elizabeth S. Delzell8, Monika M. Safford9, Jasvinder A. Singh10, Iris E. Navarro11, Grant W. Cannon12, Ted R. Mikuls13, Lang Chen11, Kenneth G. Saag14, Kimberly Alexander15, Pavel Napalkov15, Aaron Kamauu16 and Jeffrey R. Curtis17, 1Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Infectious Disease, Birmingham, AL, 4VA Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, 5Dept of Infectious Disease, Oregon Health & Science University, Portland, OR, 6VA Hospital, Jackson, MS, 7Immunology/Rheumatology, Univ of Alabama-Birmingham, Birmingham, AL, 8Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 9Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, 10Department of Medicine, University of Alabama, Tuscaloosa, AL, 11Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 12Division of Rheumatology, George E. Wahlen VA Medical Center, Salt Lake City, UT, 13Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 14Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 15Epidemiology, Genentech, Inc., South San Francisco, CA, 16Anolinx, Bountiful, UT, 17Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL

    Background/Purpose: The incidence of opportunistic infections (OIs) in patients on biologics is low, but may approach several cases per 100 person-years (PY). Data on risks…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.